Trading perpetual futures contracts in decentralized apps is a crypto sub-sector ripe for growth, especially as discussions of regulation, taxation and mandatory Know Your Customer at centralized ...

Injective is integrating a native Ethereum Virtual Machine into its Layer 1 blockchain. This new development enables Ethereum-compatible decentralized applications on Injective. The team is starting ...

Native EVM implementation achieves 800 TPS and handles 1M lightweight transactions without relying on external bridges or third-party solutions. Integration supports advanced DeFAI capabilities and on ...

Injective is a popular project among many crypto investors with many influencers calling for the price of $100 on this token, in this bull run. However, this token is yet to return the faith invested ...

In 2030, our crypto analyst team and Machine Learning experts envision a varied outlook for the Injective token. Projections indicate highs near $152.37, potential lows around $47.43, with an average ...

The Injective blockchain team plans to stake an additional 50 million INJ, raising the total staked to over 47.7% amid increasing TVL. The total value invested on Injective's decentralized finance ...

Injective Protocol, a layer-1 blockchain focused on decentralized finance, is launching onchain pre-IPO perpetual markets, giving global investors access to trade synthetic versions of major private ...

Injective's recent 12% weekly rise signals strong market confidence. Increased trading volume hints at greater liquidity and investor interest. Technical indicators suggest possible consolidation but ...

Injective targets $33.34 and $50 after a bullish flag breakout, signaling strong momentum. Market sentiment remains bullish, with rising RSI, MA cross, and increasing Open Interest. Injective [INJ] ...

Injective said it is bringing SBET, the stock for Joe Lubin’s Ethereum treasury firm SharpLink, onchain, “marking the first tokenized digital asset treasury.” SharpLink is currently the second-largest ...